Skip to main content
Premium Trial:

Request an Annual Quote

That's Entertainment!

If you're going to dance the proteome, make sure you've got plenty of friends.

That's the advice of Anna-Maria Lahesmaa-Korpinen, a researcher at the Finnish Institute of National Health and Welfare and creator of the below video —a depiction in dance of the cancer proteome.

Lahesmaa-Korpinen came up with the dance as an entry in Finland's ScienceSLAM competition — an event run by a group of Helsinki-based researchers in which scientists take the stage to present their research via performance pieces.

With a group of friends and colleagues — including a few currently studying directing and cinematography — Lahesmaa-Korpinen choreographed a take on her recently completed PhD thesis — an investigation into computational approaches in high-throughput proteomics data analysis.

A life-long dancer, "it was sort of a natural thing to use dance for communicating what I've been doing for my PhD research," Lahesmaa-Korpinen tells the Daily Scan.

As for actually putting the piece together, rounding up a large enough cast was key. "Having a dance about proteomics with only two or three dancers would have been kind of incomplete," she says.

"I also think proteomics-related studies are optimal for visualization with dance, since things like interactions, signals and structures can be quite naturally depicted using dancers," Lahesmaa-Korpinen adds.

The proteomics world may have to wait a while before it's again immortalized in dance, though. Since defending her thesis this summer Lahesmaa-Korpinen has shifted her research focus towards public health.

"I've moved away from proteomics," she says. "But, of course, I will continue following the field because it's always been inspirational and there are a lot of exciting things happening."

The choreography of the cancer proteome from Anna-Maria Lahesmaa-Korpinen on Vimeo.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.